natgillin/translations-raw huggingface dataset:
The specification of the active substance and the supported uses are the same as were the subject of Decision 2008/934/EC.
Specifikacija aktivne snovi in podprte uporabe so enake kot v Odločbi 2008/934/ES.
It has appeared from the various examinations made that plant protection products containing fenbuconazole may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which have been examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo fenbukonazol, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile preučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to include fenbuconazole in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing this active substance can be granted in accordance with the provisions of that Directive.
Zato je primerno vključiti fenbukonazol v Prilogo I, da se v vseh državah članicah v skladu z določbami navedene direktive lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo to aktivno snov.
Therefore, it is appropriate to require that the applicant submit confirmatory data on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin.
Zato je primerno zahtevati, da vlagatelj predloži potrditvene podatke o ostankih metabolitov derivatov triazola (TDM) v primarnih posevkih, posevkih, ki sledijo v kolobarju, in proizvodih živalskega izvora.
To further refine the assessment of potential endocrine disrupting properties, it is appropriate to require that fenbuconazole be subjected to further testing as soon as OECD test guidelines on endocrine disruption, or, alternatively, Community agreed test guidelines exist.
Za natančnejšo oceno lastnosti, ki lahko povzročajo motnje endokrinega sistema, je primerno zahtevati dodatne preskuse fenbukonazola, takoj ko bodo na voljo smernice OECD za preskušanje učinkov na delovanje endokrinega sistema ali smernice za preskušanje, sprejete na ravni Skupnosti.
It is therefore appropriate to amend Decision 2008/934/EC accordingly.
Zato je primerno Direktivo 2008/934/EGS ustrezno spremeniti.
The line concerning fenbuconazole in the Annex to Decision 2008/934/EC is deleted.
V Prilogi k Odločbi 2008/934/ES se črta vrstica, ki zadeva fenbukonazol.
They shall apply those provisions from 1 November 2011.
Navedene predpise uporabljajo od 1. novembra 2011.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing fenbuconazole as an active substance by 1 November 2011.
Države članice v skladu z Direktivo 91/414/EGS do 1. novembra 2011 po potrebi spremenijo ali prekličejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo fenbukonazol kot aktivno snov.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to fenbuconazole are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13 of that Directive.
Do navedenega datuma zlasti preverijo, ali so pogoji iz Priloge I k navedeni direktivi v zvezi s fenbukonazolom, z izjemo tistih iz dela B besedila o navedeni aktivni snovi, izpolnjeni in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi v skladu s pogoji iz člena 13 navedene direktive.
By way of derogation from paragraph 1, for each authorised plant protection product containing fenbuconazole as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 30 April 2011 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning fenbuconazole.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje fenbukonazol kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo I k Direktivi 91/414/EGS najpozneje do 30. aprila 2011, v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B besedila o fenbukonazolu iz Priloge I k navedeni direktivi.
in the case of a product containing fenbuconazole as the only active substance, where necessary, amend or withdraw the authorisation by 30 April 2015 at the latest; or
če sredstvo vsebuje fenbukonazol kot edino aktivno snov, najpozneje do 30. aprila 2015 po potrebi spremenijo ali prekličejo registracijo; ali
in the case of a product containing fenbuconazole as one of several active substances, where necessary, amend or withdraw the authorisation by 30 April 2015 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če sredstvo vsebuje fenbukonazol kot eno izmed več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 30. aprila 2015 ali do datuma, določenega za takšno spremembo ali preklic v ustreznih direktivah, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, pri čemer se upošteva poznejši datum.
European Food Safety Authority; Conclusion on the peer review of the pesticide risk assessment of the active substance fenbuconazole.
Evropska agencija za varnost hrane; Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo fenbukonazol.
EFSA Journal 2010; 8(4):1558.
EFSA Journal 2010; 8(4) : 1558.
CAS No: 114369-43-6
Št. CAS: 114369-43-6
CIPAC No: 694
Št. CIPAC: 694
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on fenbuconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2010 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za fenbukonazol ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 28. oktobra 2010.
the operator safety and ensure that conditions of use prescribe the application of adequate personal protective equipment where appropriate,
varnost izvajalcev ter zagotovitev, da je v pogojih uporabe po potrebi predpisana uporaba ustrezne osebne zaščitne opreme,
the dietary exposure of consumers to the residues of triazole derivative metabolites (TDMs),
prehransko izpostavljenost potrošnikov ostankom metabolitov derivatov triazola (TDM),
the risk to aquatic organisms and mammals.
tveganje za vodne organizme in sesalce.
Conditions of use shall include risk mitigation measures, where appropriate.
Pogoji uporabe po potrebi vključujejo ukrepe za zmanjšanje tveganja.
The Member States concerned shall request the submission of confirmatory data on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin.
Zadevne države članice zahtevajo predložitev potrditvenih podatkov o ostankih metabolitov derivatov triazola (TDM) v primarnih posevkih, posevkih, ki sledijo v kolobarju, in proizvodih živalskega izvora.
They shall ensure that the applicant provides such studies to the Commission by 30 April 2013.
Države članice zagotovijo, da vlagatelj Komisiji predloži take študije do 30. aprila 2013.
The Member States concerned shall ensure that the applicant submits to the Commission further information addressing the potential endocrine disrupting properties of fenbuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, of Community agreed test guidelines.’
Zadevne države članice zagotovijo, da vlagatelj Komisiji predloži dodatne informacije o lastnostih fenbukonazola, ki lahko povzročajo motnje endokrinega sistema, v dveh letih po sprejetju smernic OECD za preskušanje učinkov na delovanje endokrinega sistema ali smernic za preskušanje, sprejetih na ravni Skupnosti.“
The United Kingdom evaluated the additional data submitted by the applicant and prepared an additional report.
Združeno kraljestvo je ocenilo dodatne podatke, ki jih je predložil vlagatelj, in pripravilo dodatno poročilo.
It communicated that report to the European Food Safety Authority (hereinafter ‘the Authority’) and to the Commission on 20 July 2009.
Navedeno poročilo je 20. julija 2009 predložilo Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija) in Komisiji.
In accordance with Article 20(1) of Regulation (EC) No 33/2008 and at the request of the Commission, the Authority presented its conclusion on fenbuconazole to the Commission on 18 March 2010 [6].
Agencija je 18. marca 2010 v skladu s členom 20(1) Uredbe (ES) št. 33/2008 in na zahtevo Komisije Komisiji predstavila svoje sklepe o fenbukonazolu [6].
The draft assessment report, the additional report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 28 October 2010 in the format of the Commission review report for fenbuconazole.
Osnutek poročila o oceni, dodatno poročilo in sklep Agencije so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 28. oktobra 2010 v obliki poročila Komisije o pregledu glede fenbukonazola.
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing authorisations of plant protection products containing fenbuconazole to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should vary, replace or withdraw, as appropriate, existing authorisations, in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti iz Direktive 91/414/EGS, ki izhajajo iz vključitve aktivne snovi v Prilogo I, je državam članicam treba omogočiti, da v šestih mesecih po vključitvi snovi pregledajo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo fenbukonazol, da zagotovijo izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 in ustreznih pogojev iz Priloge I. Države članice v skladu z določbami Direktive 91/414/EGS obstoječe registracije po potrebi spremenijo, nadomestijo ali prekličejo.
Commission Decision 2008/934/EC of 5 December 2008 concerning the non-inclusion of certain active substances in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing these substances provides for the non-inclusion of fenbuconazole and the withdrawal of authorisations for plant protection products containing that substance by 31 December 2011.
Odločba Komisije 2008/934/ES z dne 5. decembra 2008 o nevključitvi nekaterih aktivnih snovi v Prilogo I k Direktivi Sveta 91/414/EGS in o preklicu registracij fitofarmacevtskih sredstev, ki vsebujejo te snovi, določa nevključitev fenbukonazola in preklic registracije fitofarmacevtskih sredstev, ki vsebujejo navedeno snov, do 31. decembra 2011.
It is necessary to delete the line concerning fenbuconazole in the Annex to that Decision.
V Prilogi k navedeni Odločbi je treba črtati vrstico, ki zadeva fenbukonazol.
Council Directive 2010/88/EU
Direktiva Sveta 2010/88/EU
amending Directive 2006/112/EC on the common system of value added tax, with regard to the duration of the obligation to respect a minimum standard rate
o spremembi Direktive 2006/112/ES o skupnem sistemu davka na dodano vrednost, v zvezi s trajanjem obveznosti spoštovanja najnižje splošne stopnje
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 113 thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije, zlasti člena 113 Pogodbe,
After transmission of the draft legislative act to the national Parliaments,
po posredovanju osnutka zakonodajnega akta nacionalnim parlamentom,
Article 97(1) of Council Directive 2006/112/EC [1] provides that from 1 January 2006 until 31 December 2010, the standard rate may not be less than 15 %.
V členu 97(1) Direktive Sveta 2006/112/ES [1] je določeno, da od 1. januarja 2006 do 31. decembra 2010 splošna stopnja ne sme biti nižja od 15 %.
The standard rate of value added tax (VAT) currently in force in various Member States, combined with the mechanism of the transitional system has ensured that this system has functioned to an acceptable degree.
Splošna stopnja davka na dodano vrednost (DDV), ki trenutno velja v različnih državah članicah, je skupaj z mehanizmom prehodne ureditve zagotovila sprejemljivo delovanje te ureditve.
With new rules on the place of supply of services which favour taxation at the place of consumption, the possibilities for exploiting differences in VAT rates through relocation have been limited further and potential distortions of competition reduced.
Nova pravila o kraju opravljanja storitev, ki podpirajo obdavčitev v kraju potrošnje, so nadalje omejila možnosti, da bi se razlike v stopnjah DDV izkoriščale s selitvami in zmanjšala morebitno izkrivljanje konkurence.
To prevent a growing divergence in the standard rates of VAT applied by the Member States from leading to structural imbalances in the European Union and distortions of competition in some sectors of activity, it is common practice in the field of indirect taxes to set minimum rates.
Da vedno večje razlike med splošnimi stopnjami DDV, ki jih uporabljajo države članice, ne bi povzročile strukturnega neravnovesja v Evropski uniji in izkrivljanja konkurence v nekaterih sektorjih, se na področju posrednih davkov navadno določijo najnižje stopnje.
It is still necessary to do so for VAT.
Pri DDV je to še vedno potrebno.
Pending the outcome of consultations on a new VAT strategy which is expected to address future arrangements and corresponding levels of harmonisation, it would be premature to set a permanent standard rate level or to consider changing the minimum rate level.
Ker posvetovanja o novi strategiji za DDV, ki naj bi obravnavala prihodnje ureditve in ustrezne ravni usklajenosti, še niso končana, je še prezgodaj, da bi se določila trajna splošna stopnja ali preučila sprememba najnižje stopnje.
It is therefore appropriate to maintain the current minimum standard rate at 15 % for a further period long enough to ensure legal certainty, while allowing further review.
Zato je treba sedanjo najnižjo stopnjo 15 % obdržati dovolj dolgo obdobje, da se zagotovi pravna varnost in hkrati omogoči nadaljnji pregled.
This does not preclude a further revision of VAT legislation before 31 December 2015 to address the outcome of the new VAT strategy.
To ne izključuje možnosti ponovne revizije zakonodaje o DDV pred 31. decembrom 2015, da bi se upoštevali rezultati nove strategije za DDV.
In accordance with point 34 of the Interinstitutional Agreement on better law-making [2], Member States are encouraged to draw up, for themselves and in the interests of the Union, their own tables which will, as far as possible, illustrate the correlation between this Directive and the transposition measures, and to make them public.
V skladu s točko 34 Medinstitucionalnega sporazuma o boljši pripravi zakonodaje [2] se države članice poziva, da za lastne potrebe in v interesu Unije pripravijo tabele, ki naj kar najbolj nazorno prikazujejo primerjavo med to direktivo in ukrepi za prenos, ter da te tabele objavijo.
Article 97 of Directive 2006/112/EC is replaced by the following:
Člen 97 Direktive 2006/112/ES se nadomesti z naslednjim:
From 1 January 2011 until 31 December 2015, the standard rate may not be lower than 15 %.’.
Od 1. januarja 2011 do 31. decembra 2015 splošna stopnja ne sme biti nižja od 15 %.“.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 January 2011 at the latest.
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo najpozneje do 1. januarja 2011.
Commission Directive 2010/89/EU
Direktiva Komisije 2010/89/EU
of 6 November 2010
z dne 6. novembra 2010
amending Council Directive 91/414/EEC to include quinmerac as active substance and amending Decision 2008/934/EC
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve kvinmeraka kot aktivne snovi in o spremembi Odločbe 2008/934/ES
That list included quinmerac.
Navedeni seznam je vključeval kvinmerak.
Consequently, Commission Decision 2008/934/EC of 5 December 2008 concerning the non-inclusion of certain active substances in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing these substances [4] was adopted on the non-inclusion of quinmerac.
Zato je bila v zvezi z nevključitvijo kvinmeraka sprejeta Odločba Komisije 2008/934/ES z dne 5. decembra 2008 o nevključitvi nekaterih aktivnih snovi v Prilogo I k Direktivi Sveta 91/414/EGS in o preklicu registracij fitofarmacevtskih sredstev, ki vsebujejo te snovi [4].
It communicated that report to the European Food Safety Authority (hereinafter ‘the Authority’) and to the Commission on 18 June 2009.
Navedeno poročilo je 18. junija 2009 predložilo Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija) in Komisiji.
In accordance with Article 20(1) of Regulation (EC) No 33/2008 and at the request of the Commission, the Authority presented its conclusion on quinmerac to the Commission on 26 February 2010 [6].
V skladu s členom 20(1) Uredbe (ES) št. 33/2008 in na zahtevo Komisije je Agencija 26. februarja 2010 Komisiji predstavila svoje sklepe o kvinmeraku [6].
The draft assessment report, the additional report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 28 October 2010 in the format of the Commission review report for quinmerac.
Osnutek poročila o oceni, dodatno poročilo in sklep Agencije so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 28. oktobra 2010 v obliki poročila Komisije o pregledu glede kvinmeraka.
It has appeared from the various examinations made that plant protection products containing quinmerac may be expected to satisfy, in general, the requirements laid down in Article 5(1) (a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which have been examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo kvinmerak, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile preučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to include quinmerac in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing this active substance can be granted in accordance with the provisions of that Directive.
Zato je primerno vključiti kvinmerak v Prilogo I, da se v vseh državah članicah v skladu z določbami navedene direktive lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo to aktivno snov.
Therefore, it is appropriate to require that the applicant submit further information to confirm the results of the risk assessment on the basis of most recent scientific knowledge as regards the potential of plant metabolism to result in an opening of the quinoline ring, the residues in rotational crops and the long term risk for earthworms due to the metabolite BH 518-5.
Zato je primerno zahtevati, da vlagatelj predloži dodatne informacije, ki potrjujejo izsledke ocene tveganja na podlagi najnovejših znanstvenih dognanj glede možnosti, da se zaradi metabolizma rastline odpre kinolinski obroč, glede ostankov v posevkih, ki sledijo v kolobarju, in glede dolgoročnega tveganja za deževnike zaradi metabolita BH 518-5.
The experience gained from previous inclusions in Annex I to Directive 91/414/EEC of active substances assessed in the framework of Commission Regulation (EEC) No 3600/92 of 11 December 1992 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8 (2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market [7] has shown that difficulties can arise in interpreting the duties of holders of existing authorisations in relation to access to data.
Izkušnje iz prejšnjih vključitev aktivnih snovi v Prilogo I k Direktivi 91/414/EGS, ocenjenih na podlagi Uredbe Komisije (EGS) št. 3600/92 z dne 11. decembra 1992 o podrobnih pravilih za izvajanje prve faze delovnega programa iz člena 8(2) Direktive Sveta 91/414/EGS o dajanju fitofarmacevtskih sredstev v promet [7], so pokazale, da se lahko pojavijo težave pri razlagi dolžnosti imetnikov obstoječih registracij v zvezi z dostopom do podatkov.
The line concerning quinmerac in the Annex to Decision 2008/934/EC is deleted.
V Prilogi k Odločbi 2008/934/ES se črta vrstica, ki zadeva kvinmerak.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing quinmerac as an active substance by 1 November 2011.
Države članice v skladu z Direktivo 91/414/EGS do 1. novembra 2011 po potrebi spremenijo ali prekličejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo kvinmerak kot aktivno snov.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to quinmerac are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13 of that Directive.
Do navedenega datuma zlasti preverijo, ali so izpolnjeni pogoji iz Priloge I k navedeni direktivi glede kvinmeraka, razen tistih iz dela B besedila o navedeni aktivni snovi, in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi pod pogoji iz člena 13 navedene direktive.
By way of derogation from paragraph 1, for each authorised plant protection product containing quinmerac as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 30 April 2011 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning quinmerac.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje kvinmerak kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo I k Direktivi 91/414/EGS najpozneje do 30. aprila 2011, v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B besedila o kvinmeraku iz Priloge I k navedeni direktivi.